TransMedics Group, Inc. (TMDX) income statement
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3034% below fair value
$85.25−8.77 (-9.33%)
Close on Nov 20, 2026Market cap $2.96BP/E 22.1Yield 0.00%
TransMedics Group, Inc. financial ratios
See a number that looks wrong?